If you have any question, please feel free to email us. We will touch with you as soon as possible.
CAS:120685-11-2
Source:Europe
Qualifications:-/-/-/-/-
Name | Midostaurin |
---|---|
Chinese name | 米哚妥林 |
Cas Number | 120685-11-2 |
Source | Europe |
Qualifications | -/-/-/-/- |
""On April 28, 2017, the U.S. Food and Drug Administration (FDA) approved the listing of midostorin for the treatment of acute myeloid leukemia (AML) with FLT3+. Midostorin is the first new drug for AML in 25 years, and The first targeted drug used in combination with chemotherapy to treat AML. Midodoline is a variety of kinase inhibitors, which can inhibit the activities of various kinases including FLT3, PKC, C-FOS, MAPK, PDGFR, CDK1, KIT, VEGF, etc. ""
Hot Tags: midostaurin api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Apremilast API, Adapalene API, Escitalopram Oxalate API, Canagliflozin API, Oseltamivir Phosphate API, Pabxilib API
Tel:+86-020-61855200-902
Fax:+86-020-66392525
Email:info@upharm.cn
Address:12th floor, No. 181, Kexue Avenue, Huangpu District, Guangzhou, China